Immediate Impact
59 standout
Citing Papers
Targeting proprotein convertase subtilisin/kexin type 9 (PCSK9): from bench to bedside
2024 Standout
An “Inclisiran First” Strategy vs Usual Care in Patients With Atherosclerotic Cardiovascular Disease
2024 Standout
Works of Tadeja Kotar being referenced
Impact of Added Fluvastatin to Standard-of-Care Treatment on Sustained Virological Response in Naïve Chronic Hepatitis C Patients Infected with Genotypes 1 and 3
2013
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Tadeja Kotar | 89 | 133 | 34 | 58 | 15 | 288 | |
| Pascale Huynen | 94 | 121 | 50 | 27 | 23 | 327 | |
| Ren-Jy Ben | 128 | 63 | 39 | 44 | 18 | 331 | |
| Ruixue Sun | 174 | 98 | 28 | 47 | 19 | 332 | |
| Gerald J. Dorff | 152 | 84 | 74 | 43 | 9 | 312 | |
| Gema Fernández‐Rivas | 130 | 74 | 51 | 22 | 26 | 309 | |
| Kouxing Zhang | 62 | 49 | 7 | 26 | 22 | 248 | |
| You La Jeon | 93 | 65 | 23 | 43 | 24 | 233 | |
| P. M. Schneeberger | 34 | 123 | 69 | 84 | 12 | 304 | |
| Olaf Anhenn | 72 | 39 | 21 | 50 | 19 | 332 | |
| Yoshiaki Yamagishi | 101 | 76 | 38 | 33 | 18 | 278 |
All Works
Loading papers...